Learn More
Medchemexpress LLC Bractoppin | 2290527-07-8 | 99.9% | 414.47 | C25H23FN4O | 50MG

Supplier: Medchemexpress LLC HY12602050MG
Bractoppin is a small-molecule research inhibitor that blocks phosphopeptide recognition by the BRCA1 tandem BRCT domain, reducing BRCA1 recruitment to DNA breaks and impairing RAD51 assembly. It is intended for in vitro and in vivo studies of the DNA damage response and cell-cycle regulation, and is supplied as a solid powder or pre-made DMSO solution for experimental flexibility.
- Potent and selective BRCA1 tBRCT inhibitor (IC50 ≈ 74 nM).
- Reduces BRCA1 foci formation and inhibits RAD51 assembly in cellular assays.
- Available as solid powder and pre-made DMSO solution for ease of use.
- High solubility in DMSO and demonstrated in vivo formulation options.
- Recommended storage conditions provided for powder and solvent solutions.
- Supplied in multiple package sizes to support varied experimental scales.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.